- Home
- NEGG vs BDTX Comparison
NEGG vs BDTX Comparison
Compare NEGG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- BDTX
- Stock Information
- Founded
- NEGG 2001
- BDTX 2014
- Country
- NEGG United States
- BDTX United States
- Employees
- NEGG N/A
- BDTX N/A
- Industry
- NEGG Other Specialty Stores
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEGG Consumer Discretionary
- BDTX Health Care
- Exchange
- NEGG Nasdaq
- BDTX Nasdaq
- Market Cap
- NEGG 116.0M
- BDTX 96.9M
- IPO Year
- NEGG 2010
- BDTX 2020
- Fundamental
- Price
- NEGG $0.25
- BDTX $1.57
- Analyst Decision
- NEGG
- BDTX Strong Buy
- Analyst Count
- NEGG 0
- BDTX 5
- Target Price
- NEGG N/A
- BDTX $15.60
- AVG Volume (30 Days)
- NEGG 703.9K
- BDTX 8.3M
- Earning Date
- NEGG 04-23-2025
- BDTX 03-06-2025
- Dividend Yield
- NEGG N/A
- BDTX N/A
- EPS Growth
- NEGG N/A
- BDTX N/A
- EPS
- NEGG N/A
- BDTX N/A
- Revenue
- NEGG $1,391,833,000.00
- BDTX N/A
- Revenue This Year
- NEGG $6.01
- BDTX N/A
- Revenue Next Year
- NEGG N/A
- BDTX N/A
- P/E Ratio
- NEGG N/A
- BDTX N/A
- Revenue Growth
- NEGG N/A
- BDTX N/A
- 52 Week Low
- NEGG $0.24
- BDTX $1.51
- 52 Week High
- NEGG $1.32
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- NEGG 27.51
- BDTX 37.67
- Support Level
- NEGG $0.25
- BDTX $1.55
- Resistance Level
- NEGG $0.32
- BDTX $1.84
- Average True Range (ATR)
- NEGG 0.03
- BDTX 0.22
- MACD
- NEGG -0.00
- BDTX 0.00
- Stochastic Oscillator
- NEGG 8.12
- BDTX 5.88
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.